SCHEMBL27512387

SCHEMBL27512387

Cc1cc(C)c(NC(=O)c2sccc2S(=O)(=O)Nc2onc(C)c2Cl)c(CCC(C)C)c1

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EDNRA P25101 20/20 0.82
▸ EDNRB P24530 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4631810 0.91 EDNRA (0.86) EDNRAEDNRB
SCHEMBL5206860 0.90 EDNRA (1.00) EDNRAEDNRB
SCHEMBL4630737 0.88 EDNRA (1.00) EDNRAEDNRB
SCHEMBL7343101 0.88 EDNRA (1.00) EDNRAEDNRB
SCHEMBL27514463 0.88 EDNRA (0.71) EDNRAEDNRB
SCHEMBL27514464 0.86 EDNRA (0.61) EDNRAEDNRB
SCHEMBL4631331 0.86 EDNRA (1.00) EDNRAEDNRB
SCHEMBL5210566 0.86 EDNRA (1.00) EDNRAEDNRB
SCHEMBL4630720 0.85 EDNRA (0.81) EDNRAEDNRB
SCHEMBL5211878 0.85 EDNRA (0.83) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1253560-A Sulfonamides for the treatment of endothelin mediated diseases TEXA BIOTECHNOLOGY CORP (US) 2000-05-17 — — CN claimed
CN-1253560-A Sulfonamides for the treatment of endothelin mediated diseases TEXA BIOTECHNOLOGY CORP (US) 2000-05-17 — — CN disclosed
Send feedback